Search
-
Ipsos Update - October 2024
Trends, News, Ageing … Ipsos Update explores the latest and research & thinking on key topics from Ipsos teams around the world.
-
Predicting Opportunity in Emerging Therapies
The advent of groundbreaking therapies in the metabolic sector, including GLP-1, offers substantial opportunities for pharmaceutical companies, yet accurately estimating the size of these emerging markets, marked by significant unmet clinical needs, presents distinct challenges.
-
Conversations with AI Part V: Is there depth and empathy with AI twins?
How do synthetic respondents fall short of capturing the human experience?
-
[WEBINAR] Cannes 2024: 6(0) Shades of Context for Brand Success
Join our exclusive webinar, 'Ipsos Cannes Trends Review 2024: 6(0) Shades of Cannes Context,' on October 1st
-
Ipsos Update – September 2024
Data, Healthcare, Education … Ipsos Update explores the latest and research & thinking on key topics from Ipsos teams around the world.
-
Rare Diseases: A Diagnostic Odyssey
Unravelling the Complexities of Rare Diseases: A Market Research Perspective
-
Ipsos launches a voluntary public takeover offer for infas to acquire the industry leader in German public sector research
Voluntary public takeover offer
-
Americans increasingly concerned about inflation as U.S. election nears
50% of people in the U.S. now say the cost of living is the top concern for their country as persistent fears about a recession hang overhead.
-
Conversations with AI Part IV: AI-assisted knowledge libraries and curation, the search for a trusted output
This Ipsos Views white paper explores the role of AI as part of curation and how human expertise and AI speed can work best together.
-
Bringing Healthcare Segmentations to Life: The Dawn of the GenAI-Powered Persona
Enter the age of generative AI, ushering in a new era of possibility with the advent of the persona bot – a tool with the potential to revolutionise how pharmaceutical companies activate and leverage segmentation data.